Skip to content
Top Menu
  • Log In
  • Register
  • Facebook
  • Twitter
  • LinkedIn
MyChesCo

MyChesCo

Chester County News and Community Website

  • Communities
    • Avondale
    • Berwyn
    • Coatesville
    • Cochranville
    • Devon
    • Downingtown
    • Exton
    • Honey Brook
    • Kennett Square
    • Malvern
    • Oxford
    • Paoli
    • Parkesburg
    • Phoenixville
    • Spring City
    • Toughkenamon
    • West Chester
    • West Grove
  • Education
    • Chester County Intermediate Unit
    • School Districts
      • Avon Grove School District
      • Coatesville Area School District
      • Downingtown Area School District
      • Great Valley School District
      • Kennett Consolidated School District
      • Octorara Area School District
      • Owen J. Roberts School District
      • Oxford Area School District
      • Phoenixville Area School District
      • Spring-Ford Area School District
      • Tredyffrin-Easttown School District
      • Twin Valley School District
      • Unionville-Chadds Ford School District
      • West Chester Area School District
    • Charter Schools
    • Independent Schools
    • Colleges and Universities
    • Chester County Library System
  • News
    • Traffic
    • Weather
    • Business
    • Health / Medical
    • National
    • Pennsylvania
    • Sports
  • Entertainment
  • Lifestyle
  • Tools
    • Members
    • Groups
    • Submit an Article
    • Contact Us
    • Signup for Newsletter
    • Contests and Giveaways
    • Gas Prices
    • Register
    • Log In
  • About
    • MyChesCo
    • Writing for Us
    • Advertising with Us
    • Contacting Us
    • Citizen Journalism
    • Submitting Articles
    • Starting a Group
    • How to Support Us
    • Terms of Service
    • Privacy Policy
    • DMCA Policy
    • AI Disclosure
  • Shop

Breast cancer

AstraZeneca
Cancer / Regional

AstraZeneca Breast Cancer Drug Extends Progression-Free Survival

June 12, 2026June 11, 2026 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca reported updated Phase III trial results showing its investigational breast cancer therapy camizestrant extended the time patients lived without disease progression and delayed the need for …

AstraZeneca Breast Cancer Drug Extends Progression-Free Survival Read More

AstraZeneca
Cancer / Regional

AstraZeneca, Daiichi Sankyo Win FDA Approval for DATROWAY in Breast Cancer

June 3, 2026June 2, 2026 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca and Daiichi Sankyo have secured U.S. approval for DATROWAY as a first-line treatment for certain patients with metastatic triple-negative breast cancer, expanding treatment options in a …

AstraZeneca, Daiichi Sankyo Win FDA Approval for DATROWAY in Breast Cancer Read More
Breast Cancer Awareness
Regional

Susan G. Komen Expands Pennsylvania Fundraising Effort

May 11, 2026May 10, 2026 - by Timothy Alexander

PHILADELPHIA, PA — Susan G. Komen plans to raise a combined $725,000 through breast cancer fundraising walks in Philadelphia and Pittsburgh this month as cancer advocacy groups face growing demand …

Susan G. Komen Expands Pennsylvania Fundraising Effort Read More

AstraZeneca
Cancer / Regional

FDA Grants Priority Review to ENHERTU for Early Breast Cancer Use

March 20, 2026March 19, 2026 - by Timothy Alexander

WILMINGTON, DE — The U.S. Food and Drug Administration has accepted and granted Priority Review to a supplemental application for ENHERTU, a breast cancer treatment developed by AstraZeneca and Daiichi …

FDA Grants Priority Review to ENHERTU for Early Breast Cancer Use Read More
AstraZeneca
Regional

DATROWAY Gains Priority Review for Aggressive Breast Cancer

February 12, 2026February 11, 2026 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca and Daiichi Sankyo’s supplemental Biologics License Application for DATROWAY® (datopotamab deruxtecan-dlnk) has been accepted and granted Priority Review by the U.S. Food and Drug Administration for …

DATROWAY Gains Priority Review for Aggressive Breast Cancer Read More

AstraZeneca
Regional

ENHERTU Scores Tenth FDA Fast-Track as Breast Cancer Data Shifts Playbook

December 31, 2025December 30, 2025 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca (NASDAQ: AZN) and Daiichi Sankyo (TYO: 4568) said their jointly developed breast cancer therapy ENHERTU has received Breakthrough Therapy Designation from the U.S. Food and Drug …

ENHERTU Scores Tenth FDA Fast-Track as Breast Cancer Data Shifts Playbook Read More
AstraZeneca
Regional

FDA Clears ENHERTU Combo as First-Line Breakthrough in HER2 Breast Cancer

December 28, 2025December 26, 2025 - by Timothy Alexander

WILMINGTON, DE — AstraZeneca PLC (NASDAQ: AZN) and Japan’s Daiichi Sankyo said the U.S. Food and Drug Administration has approved ENHERTU in combination with pertuzumab as a first-line treatment for …

FDA Clears ENHERTU Combo as First-Line Breakthrough in HER2 Breast Cancer Read More

Care for HER
Regional

New Data Shows Care Model Dramatically Improves Black Breast Cancer Outcomes

December 21, 2025December 20, 2025 - by Timothy Alexander

ANNAPOLIS, MD & PHILADELPHIA, PA — Two national breast cancer nonprofits unveiled new research showing significant gains in health outcomes and quality of life for Black women with breast cancer, …

New Data Shows Care Model Dramatically Improves Black Breast Cancer Outcomes Read More
National Comprehensive Cancer Network
Regional / Research

New Research Funding Targets Gaps in Care for Stage Four Breast Cancer

December 19, 2025December 17, 2025 - by Timothy Alexander

PLYMOUTH MEETING, PA — The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program has announced new funding aimed at improving treatment and care delivery for people living with metastatic, or …

New Research Funding Targets Gaps in Care for Stage Four Breast Cancer Read More
Zombie Fun Run 5K
Regional

Zombies, Mud, and a Cause: Field of Screams Run Raises $8,400 for Cancer Care

December 14, 2025December 12, 2025 - by Timothy Alexander

MOUNTVILLE, PA — Field of Screams turned adrenaline and community spirit into tangible impact this fall, raising $8,400 for the Pennsylvania Breast Cancer Coalition during its 13th annual Zombie Fun …

Zombies, Mud, and a Cause: Field of Screams Run Raises $8,400 for Cancer Care Read More

Posts pagination

1 2 3 Next

Trending News

  • Daycare Employee Charged After Child Assault Allegation

  • BLAST Robotics Expands Summer STEM Program Through Industry Partnerships

  • Two Chester County Roads Face Weeklong Traffic Disruptions

  • Longwood Gardens Opens Its Gates for Pay-What-You-Wish Day in Kennett Square

  • This U.S. 30 Work Could Disrupt Overnight Travel

Subscribe for Updates

Follow Us

  • Facebook
  • X
  • LinkedIn
  • Google
  • RSS Feed

Tools

  • Members
  • Newsletter
  • Events
  • Groups
  • Guest Articles
  • Coupon Center
  • Gas Prices
  • Log In
  • Register

About Us

  • About MyChesCo
  • Advertise
  • Contact Us
  • Support Us
  • Write for Us
  • Terms of Service
  • Privacy Policy
  • DMCA Policy
  • Affiliate Disclaimer

Recommended Reading

Thomas Coleman

Daycare Employee Charged After Child Assault Allegation

3 minutes ago2 hours ago

Police News

Teen Suffers Serious Eye Injury in BB Gun Shooting

18 hours agoJune 19, 2026

Tanekqua Stanford

Two Cases, One Suspect: Wilmington Police Make Arrest

19 hours agoJune 19, 2026

Copyright © 2026 MyChesCo.